Evidence mapPaperPMID 40508213Full record

Observational studyInternational journal of molecular sciences2025

Alpha1-Antitrypsin in Lung Diseases: A Cross-Sectional Observational Study.

Csilla Páska, Imre Barta, Zsuzsanna Csoma, Réka Gajdócsi, Viktória Szél, Anna Kerpel-Fronius, Diána Solymosi, Zoltán Örlős, Balázs Antus

Abstract readObservational Study
In one paragraph

Observational study in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Csilla PáskaNational Korányi Institute for Pulmonology, Korányi Frigyes út. 1, 1121 Budapest, Hungary.
Imre BartaNational Korányi Institute for Pulmonology, Korányi Frigyes út. 1, 1121 Budapest, Hungary.ORCID 0000-0003-0067-5166
Zsuzsanna CsomaNational Korányi Institute for Pulmonology, Korányi Frigyes út. 1, 1121 Budapest, Hungary.
Réka GajdócsiNational Korányi Institute for Pulmonology, Korányi Frigyes út. 1, 1121 Budapest, Hungary.
Viktória SzélNational Korányi Institute for Pulmonology, Korányi Frigyes út. 1, 1121 Budapest, Hungary.
Anna Kerpel-FroniusNational Korányi Institute for Pulmonology, Korányi Frigyes út. 1, 1121 Budapest, Hungary.ORCID 0000-0002-8616-3366
Diána SolymosiNational Korányi Institute for Pulmonology, Korányi Frigyes út. 1, 1121 Budapest, Hungary.
Zoltán ÖrlősNational Korányi Institute for Pulmonology, Korányi Frigyes út. 1, 1121 Budapest, Hungary.
Balázs AntusNational Korányi Institute for Pulmonology, Korányi Frigyes út. 1, 1121 Budapest, Hungary.

Funding

Hungarian National Research, Development and Innovation Office NKFIH; 2020-1.1.6-JÖVŐ-2021-00003
6 · The paper itself

Abstract

Major mutations of

Indexed as

alpha 1-AntitrypsinLung DiseasesAdultAgedCross-Sectional StudiesFemaleHumansLung Diseases, InterstitialMaleMiddle AgedMutationPolymorphism, Single NucleotidePulmonary Disease, Chronic ObstructiveSmokingalpha 1-AntitrypsinSERPINA1 protein, humanantitrypsinasthmaCOPDcystic fibrosisILDlung pathologiessarcoidosis

Identifiers

PMID40508213
PMCPMC12155688

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.